BRENDON M. COUGHTRY M.D. NPI 1669514840

NPI Details

Brendon M. Coughtry, M.D. is an interventional pain medicine pain medicine in Campbellsville, KY with 22 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. Brendon M. Coughtry, M.D. NPI is 1669514840. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

99 WELLPARK LANE
STE 4
CAMPBELLSVILLE, KY
ZIP 42718-919
Phone: (606) 260-8613
Fax: (859) 977-2683

The NPI 1669514840 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional (HCPCS:99484)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)

The enumeration date for this NPI number is 2/13/2007 and was last updated on 2/13/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.